Skip to main content
10 December 2019
Last updated:
Tuesday 10 December 2019

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

IPR & Legal

Johnson & Johnson settles opioid suits

Saturday 5 October 2019
Country

United States

Johnson & Johnson Inc became the latest pharmaceutical company on 1 October to settle lawsuits brought by two counties in Ohio over its alleged role in the US opioid epidemic. J&J agreed to a settlement of $20.4 million, thereby avoiding a trial in federal court. The settlement includes no admission of liability.

Read more

EU proposes e-commerce rules

Friday 3 May 2019
Country

Belgium

The European Commission has published proposed rules for electronic commerce that, among other things, would guarantee the validity of e-contracts and e-signatures and introduce measures to combat spam. The proposal has been introduced within the context of ongoing negotiations among World Trade Organization members about making e-commerce more transparent and reliable.
“Despite a fast increase in digital trade, there are currently no multilateral rules in this area,”
the Commission said in a statement issued on 3 May.

Read more

New US patent awarded to Charpentier and collaborators

Friday 26 April 2019
Country

Ireland

The US Patent and Trademark Office has issued a new patent to Emmanuelle Charpentier and colleagues for their work on the gene editing technology CRISPR-Cas9. The patent, granted to Dr Charpentier, the Regents of the University of California and the University of Vienna, focuses on systems and methods for using the CRISPR-Cas9 technology in a single guide format, including uses to target and edit or modulate genes, according to ERS Genomics Ltd, an Ireland-based company created to provide access to the technology.

Read more

UK High Court says EMA is bound by lease

Thursday 21 February 2019
Country

United Kingdom

The European Medicines Agency (EMA) has been told it will have to continue servicing the lease covering its former London headquarters even as it completes plans for a move to Amsterdam. The move to Amsterdam follows the UK’s 2016 vote to leave the EU.

The UK High Court ruled on 20 February that the move “was not required as a matter of law.” Therefore the agency’s rental contract remains in force along with the landlord’s right to collect rent. The case was brought by the property company Canary Wharf Ltd.

Read more

MorphoSys says patent suit settled

Sunday 10 February 2019
Country

Germany

Patent litigation involving two of Europe’s most important antibody companies plus Janssen Biotech formally ended on 31 January after the parties agreed to drop their mutual claims. The lawsuit was brought by MorphoSys AG against Genmab A/S and its partner Janssen relating to Darzalex (daratumumab), the latter companies’ marketed drug for multiple myeloma.

Read more

US court declares MorphoSys patents invalid

Saturday 26 January 2019
Country

Germany

A US district court has ruled against MorphoSys AG in a patent infringement suit that the Germany company brought against Genmab A/S and its partner Janssen Biotech Inc relating to Darzalex (daratumumab), their marketed drug for multiple myeloma.

The decision, by the District Court of Delaware, means that MorphoSys’ claims for damage have been rejected and its three US patents for a similar drug have been declared invalid.

Read more

UK can unilaterally revoke Brexit, court says

Monday 10 December 2018
Country

Luxembourg

The UK, on the basis of a democratic decision, can unilaterally revoke a decision to withdraw from the EU as long as the withdrawal agreement has not entered into force, the Court of Justice of the European Union, announced on 10 December.

Read more

The enforcer of data protection steps into the spotlight

Wednesday 30 May 2018
Country

Belgium

With the introduction on 25 May of data protection regulations for companies inside the European Community and the outside companies that trade with Europe, a new entity called the European Data Protection Board (EDPB) began operations by holding a press conference in Brussels.

Read more

ViiV Healthcare sues Gilead over patent

Thursday 8 February 2018
Country

United Kingdom

ViiV Healthcare Ltd, the specialist HIV company majority-owned by GlaxoSmithKline Plc, has filed a patent infringement suit against Gilead Sciences Inc over bictegravir, an integrase inhibitor that is part of a combination therapy approved in the US on 7 February.

Read more

Insulin producers accused of price manipulation

Wednesday 1 February 2017
Country

United States

The US law firm, Hagens Berman Sobol Shapiro LLP, has filed a class action suit against Sanofi SA, Novo Nordisk A/S and Eli Lilly and Company alleging that they have used increasingly wider discounts from the list price of their analogue insulins to gain favour with pharmacy benefit managers and health insurers and thereby gained market share.

Read more

Pagination

  • Page 1
  • Next page ››
Subscribe to IPR & Legal

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Jacques Biton joins supervisory board at Nosopharm
Sunday December 8 2019
Norman Baylor joins science board at Valneva
Sunday December 8 2019
Vectura appoints Will Downie as CEO
Sunday December 8 2019
Santhera appoints Dario Eklund as CEO
Sunday December 8 2019
Robin Bhattacherjee is new CEO at Actimed
Sunday December 8 2019

© 2019 Evernow Publishing Ltd. Powered by Drupal.